Tradestie Institutional Equity Comparison Engine

OLB vs KTTA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KTTA Overall Edge

KTTA Captures Institutional Edge (2โ€“0 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pasithea Therapeutics Corp. Common Stock (KTTA) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, OLB trades at N/M Forward P/E with -73.3% operating margin (-43.6% YoY revenue) versus KTTA at N/M Forward P/E and 0.0% operating margin (+1498.1% YoY). In options structure, OLB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against KTTA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
OLB N/M vs KTTA N/M Fwd P/E
Growth & Margin Winner KTTA
Op Margin -73.3% vs 0.0% ยท YoY -43.6% vs +1498.1%
Momentum & Technical Winner KTTA
1Y -87.4% vs +0.6% ยท 52W Pos 0% vs 11%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
OLB NASDAQ
The OLB Group, Inc. Common Stock
Services-Business Services, Nec
$0.12
-4.33% 1D
Market Cap $3.8M
1M Return -63.26%
1Y Return -87.36%
Forward P/E N/M
Unified AI Score
48.6 / 100 HOLD
Tech 48.0 Fund 46.0 Flow 50.0 Mom 60.0
KTTA NASDAQ
Pasithea Therapeutics Corp. Common Stock
Pharmaceutical Preparations
$0.48
-0.48% 1D
Market Cap $17.7M
1M Return +7.52%
1Y Return +0.59%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 20.0 Fund 40.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OLB -87.36% KTTA +0.59% Spread: +87.95 pp (KTTA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period OLB Revenue KTTA Revenue OLB Op. Margin KTTA Op. Margin Margin Edge
FY2018 $10M N/A 5.9% N/A OLB
FY2019 $10M N/A -2.6% N/A OLB
FY2020 $10M N/A -7.5% N/A OLB
FY2021 $20M $0M -28.5% -29925.7% OLB
FY2022 $30M $0M -26.9% -2587.3% OLB
FY2023 $30M N/A -76.8% N/A OLB
FY2024 $10M N/A -90.9% N/A OLB
FY2025 $10M N/A -59.5% N/A OLB

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OLB (3) vs KTTA (5)
Institutional Metric OLB KTTA Criterion Row Winner
Market Capitalization Scale $3.8M $17.7M Larger Scale KTTA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -43.6% +1498.1% Higher Growth KTTA
Operating Margin (TTM) Profitability -73.3% 0.0% Higher Margin KTTA
Net Profit Margin Profitability -68.2% 0.0% Higher Margin KTTA
Return on Equity (ROE) Capital Efficiency -70.8% -88.8% Higher ROE OLB
52-Week Range Position Momentum 0% ($0โ€“$2) 11% ($0โ€“$2) Stronger Trend KTTA
Beta / 30D Volatility Risk Regime 1.80ฮฒ ยท 120% Vol 0.68ฮฒ ยท 185% Vol Lower Realized Risk OLB
Unified Institutional Score Composite Signal 48.6 / 100 (HOLD) 42.1 / 100 (HOLD) Higher Composite OLB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OLB vs KTTA Buy Guide
OLB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OLB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
KTTA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live KTTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OLB nor KTTA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.